HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain

Virology

Volumn 464-465, Issue 1, 2014, Pages 375-384

  Bolduan, Sebastian ^a,b   Reif, Tatjana ^a   Schindler, Michael ^b,c   Schubert, Ulrich ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CD155; HIV 1; Nef; SIV; Vpu

Indexed keywords

ALANINE; CD155 ANTIGEN; CD4 ANTIGEN; CELL SURFACE PROTEIN; LYMPHOCYTE ANTIGEN; NATURAL KILLER CELL RECEPTOR NATURAL KILLER CELL T LYMPHOCYTE B LYMPHOCYTE ANTIGEN; NEF PROTEIN; TETHERIN; UNCLASSIFIED DRUG; VPU PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; POLIOVIRUS RECEPTOR; VIRUS PROTEIN; VIRUS RECEPTOR; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ALPHA HELIX; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LENTIVIRINAE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; VIRUS STRAIN; VIRUS VIRULENCE; CD8+ T LYMPHOCYTE; CELL MEMBRANE; CHEMISTRY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

ALANINE; AMINO ACID MOTIFS; CD8-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; DOWN-REGULATION; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84905669765     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.07.034     Document Type: Article

References (40)

1. Banning C., Votteler J., Hoffmann D., Koppensteiner H., Warmer M., Reimer R., Kirchhoff F., Schubert U., Hauber J., Schindler M. A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS One 2010, 5:e9344.
2. Binette J., Dube M., Mercier J., Halawani D., Latterich M., Cohen E.A. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology 2007, 4:75.
3. Bolduan S., Hubel P., Reif T., Lodermeyer V., Hohne K., Fritz J.V., Sauter D., Kirchhoff F., Fackler O.T., Schindler M., Schubert U. HIV-1 Vpu affects the anterograde transport and the glycosylation pattern of NTB-A. Virology 2013, 440:190-203.
4. Bolduan S., Votteler J., Lodermeyer V., Greiner T., Koppensteiner H., Schindler M., Thiel G., Schubert U. Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317. Virology 2011, 416:75-85.
5. Cerboni C., Neri F., Casartelli N., Zingoni A., Cosman D., Rossi P., Santoni A., Doria M. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J. Gen. Virol. 2007, 88:242-250.
6. Cohen E.A., Terwilliger E.F., Sodroski J.G., Haseltine W.A. Identification of a protein encoded by the vpu gene of HIV-1. Nature 1988, 334:532-534.
7. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999, 10:661-671.
8. Dube M., Roy B.B., Guiot-Guillain P., Binette J., Mercier J., Chiasson A., Cohen E.A. Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 2010, 6:e1000856.
9. Dube M., Roy B.B., Guiot-Guillain P., Mercier J., Binette J., Leung G., Cohen E.A. Suppression of tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J. Virol. 2009, 83:4574-4590.
10. + T cells. AIDS 2009, 23:1077-1087.
11. Iwabu Y., Fujita H., Kinomoto M., Kaneko K., Ishizaka Y., Tanaka Y., Sata T., Tokunaga K. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 2009, 284:35060-35072.
12. Klimkait T., Strebel K., Hoggan M.D., Martin M.A., Orenstein J.M. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 1990, 64:621-629.
13. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
14. Magadan J.G., Perez-Victoria F.J., Sougrat R., Ye Y., Strebel K., Bonifacino J.S. Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 2010, 6:e1000869.
15. Maldarelli F., Chen M.Y., Willey R.L., Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 1993, 67:5056-5061.
16. Matusali G., Potesta M., Santoni A., Cerboni C., Doria M. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J. Virol. 2012, 86:4496-4504.
17. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
18. Norman J.M., Mashiba M., McNamara L.A., Onafuwa-Nuga A., Chiari-Fort E., Shen W., Collins K.L. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat. Immunol. 2011, 12:975-983.
19. Pacyniak E., Gomez M.L., Gomez L.M., Mulcahy E.R., Jackson M., Hout D.R., Wisdom B.J., Stephens E.B. Identification of a region within the cytoplasmic domain of the subtype B Vpu protein of human immunodeficiency virus type 1 (HIV-1) that is responsible for retention in the golgi complex and its absence in the Vpu protein from a subtype C HIV-1. AIDS Res. Hum. Retrovir. 2005, 21:379-394.
20. Rong L., Zhang J., Lu J., Pan Q., Lorgeoux R.P., Aloysius C., Guo F., Liu S.L., Wainberg M.A., Liang C. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J. Virol. 2009, 83:7536-7546.
21. Sauter D., Hue S., Petit S.J., Plantier J.C., Towers G.J., Kirchhoff F., Gupta R.K. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef. Retrovirology 2011, 8:103.
22. Sauter D., Schindler M., Specht A., Landford W.N., Munch J., Kim K.A., Votteler J., Schubert U., Bibollet-Ruche F., Keele B.F., Takehisa J., Ogando Y., Ochsenbauer C., Kappes J.C., Ayouba A., Peeters M., Learn G.H., Shaw G., Sharp P.M., Bieniasz P., Hahn B.H., Hatziioannou T., Kirchhoff F. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009, 6:409-421.
23. Schindler M., Rajan D., Banning C., Wimmer P., Koppensteiner H., Iwanski A., Specht A., Sauter D., Dobner T., Kirchhoff F. Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue. Retrovirology 2010, 7:1.
24. Schindler M., Wurfl S., Benaroch P., Greenough T.C., Daniels R., Easterbrook P., Brenner M., Munch J., Kirchhoff F. Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J. Virol. 2003, 77:10548-10556.
25. Schmidt S., Fritz J.V., Bitzegeio J., Fackler O.T., Keppler O.T. HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction. MBio 2011, 2. (e00036-00011).
26. Schubert U., Anton L.C., Bacik I., Cox J.H., Bour S., Bennink J.R., Orlowski M., Strebel K., Yewdell J.W. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 1998, 72:2280-2288.
27. Shah A.H., Sowrirajan B., Davis Z.B., Ward J.P., Campbell E.M., Planelles V., Barker E. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 2010, 8:397-409.
28. Shibuya A., Campbell D., Hannum C., Yssel H., Franz-Bacon K., McClanahan T., Kitamura T., Nicholl J., Sutherland G.R., Lanier L.L., Phillips J.H. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996, 4:573-581.
29. Shikano S., Li M. Membrane receptor trafficking: evidence of proximal and distal zones conferred by two independent endoplasmic reticulum localization signals. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5783-5788.
30. Skasko M., Tokarev A., Chen C.C., Fischer W.B., Pillai S.K., Guatelli J. BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action. Virology 2011, 411:65-77.
31. Skasko M., Wang Y., Tian Y., Tokarev A., Munguia J., Ruiz A., Stephens E.B., Opella S.J., Guatelli J. HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions. J. Biol. Chem. 2012, 287:58-67.
32. Strebel K., Klimkait T., Martin M.A. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 1988, 241:1221-1223.
33. Takai Y., Miyoshi J., Ikeda W., Ogita H. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat. Rev. Mol. Cell Biol. 2008, 9:603-615.
34. Van Damme N., Goff D., Katsura C., Jorgenson R.L., Mitchell R., Johnson M.C., Stephens E.B., Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252.
35. Vassena L., Giuliani E., Matusali G., Cohen E.A., Doria M. The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway. J. Gen. Virol. 2013, 94:2664-2669.
36. Vigan R., Neil S.J. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein. J. Virol. 2010, 84:12958-12970.
37. Vigan R., Neil S.J. Separable determinants of subcellular localization and interaction account for the inability of group O HIV-1 Vpu to counteract tetherin. J. Virol. 2011, 85:9737-9748.
38. Ward J., Davis Z., DeHart J., Zimmerman E., Bosque A., Brunetta E., Mavilio D., Planelles V., Barker E. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 2009, 5:e1000613.
39. Wildum S., Schindler M., Munch J., Kirchhoff F. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J. Virol. 2006, 80:8047-8059.
40. Willey R.L., Maldarelli F., Martin M.A., Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 1992, 66:7193-7200.